Veerhealth Care

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE882C01035
  • NSEID: NIYATILEAS
  • BSEID: 511523
INR
28.24
0.53 (1.91%)
BSENSE

Jun 18

BSE+NSE Vol: 1.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kabra Drugs
Veerhealth Care
Biofil Chemicals
Vivo Bio Tech
Rajnish Wellness
Vasundhara Rasy.
Vista Pharma.
Mangalam Drugs
Bacil Pharma
Shelter Pharma
Goldline Pharmac
Why is Veerhealth Care Ltd ?
1
Weak Long Term Fundamental Strength with a 7.26% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.28
  • The company has been able to generate a Return on Equity (avg) of 2.72% signifying low profitability per unit of shareholders funds
2
The company has declared Positive results for the last 4 consecutive quarters
  • NET SALES(Latest six months) At Rs 11.24 cr has Grown at 25.03%
  • PBDIT(Q) Highest at Rs 1.24 cr.
  • PBT LESS OI(Q) Highest at Rs 0.78 cr.
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 16-Apr-26 and has generated 18.59% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROE of 3.6, it has a Very Expensive valuation with a 2.1 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 71.60%, its profits have risen by 85% ; the PEG ratio of the company is 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Veerhealth Care should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Veerhealth Care for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Veerhealth Care
56.89%
1.95
36.65%
Sensex
-5.44%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
25.18%
EBIT Growth (5y)
21.06%
EBIT to Interest (avg)
-0.06
Debt to EBITDA (avg)
1.67
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.70
Tax Ratio
56.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-0.10%
ROE (avg)
2.92%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
65
Industry P/E
23
Price to Book Value
2.42
EV to EBIT
50.45
EV to EBITDA
24.10
EV to Capital Employed
2.20
EV to Sales
1.83
PEG Ratio
0.55
Dividend Yield
NA
ROCE (Latest)
4.36%
ROE (Latest)
3.71%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
NET SALES(Latest six months)

Higher at Rs 24.02 cr

-1What is not working for the Company
EPS(Q)

Lowest at Rs -0.18

Loading Valuation Snapshot...
Here's what is working for Veerhealth Care
Net Sales - Latest six months
At Rs 24.02 cr has Grown at 153.91%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Latest six months
Higher at Rs 24.02 cr
than preceding 12 month period ended Mar 2026 of Rs 17.93 cr
MOJO Watch
In the half year the company has already crossed sales of the previous twelve months

Net Sales (Rs Cr)

Here's what is not working for Veerhealth Care
Earnings per Share (EPS) - Quarterly
Lowest at Rs -0.18
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)